Jennifer F. Iaci - Concepedia

Author

Jennifer F. Iaci

Acorda Therapeutics (United States)

Also Known As

Iaci, Jennifer F, J Iaci, Jennifer F Iaci, Jennifer F. Iaci, Jennifer Iaci

Publications

473

Citations

H-Index

Concepts

All Affiliations

Acorda Therapeutics (United States)University of North Carolina at Chapel Hill NeuroMetrix (United States)

About

Jennifer F. Iaci is an author at Acorda Therapeutics (United States) specializing in medicine, neurology, and neurorehabilitation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	290
2	Social Sciences	2	2	44
3	Hepatology	2	2	55
4	Health Sciences	1	1	18
5	Metabolism	1	1	18

Jennifer F. Iaci

Publications

415

Citations

H-Index

Page 1

	Year	Citations
Chondroitinase improves anatomical and functional outcomes after primate spinal cord injury E Rosenzweig, Ernesto A. Salegio, Justine J. Liang, Nature Neuroscience Regenerative MedicineNeuroregenerationSpinal Cord InjuryFunctional OutcomesPeripheral Nerve Injury	2019	126
Chondroitin Sulfate Proteoglycans in Spinal Cord Contusion Injury and the Effects of Chondroitinase Treatment Jennifer F. Iaci, Andrea Vecchione, Michael Zimber, Journal of Neurotrauma MechanobiologySpinal Cord InjuryPeripheral Nerve InjuryChondroitinase TreatmentCspg Protein	2007	52
Intravenous Glial Growth Factor 2 (GGF2) Isoform of Neuregulin-1β Improves Left Ventricular Function, Gene and Protein Expression in Rats after Myocardial Infarction Michael F. Hill, Amish V. Patel, Abigail Murphy, PLoS ONE	2013	37
Refining Liver Safety Risk Assessment: Application of Mechanistic Modeling and Serum Biomarkers to Cimaglermin Alfa (GGF2) Clinical Trials DM Longo, GT Generaux, SQ Siler, Clinical Pharmacology & Therapeutics Heart FailureCimaglermin AlfaHepatologyMechanistic ModelingMechanistic Biomarkers	2017	37
Glial growth factor 2 promotes functional recovery with treatment initiated up to 7 days after permanent focal ischemic stroke Jennifer F. Iaci, Anindita Ganguly, Seth P. Finklestein, Neuropharmacology Promotes Functional RecoveryNeuroregenerationStroke RehabilitationIschemic StrokeMedicine	2010	26
The Evaluation of Magnesium Chloride within a Polyethylene Glycol Formulation in a Porcine Model of Acute Spinal Cord Injury Femke Streijger, Jae H.T. Lee, Neda Manouchehri, Journal of Neurotrauma	2016	26
GGF2 Is Neuroprotective in a Rat Model of Cavernous Nerve Injury-Induced Erectile Dysfunction Arthur L. Burnett, Sena F. Sezen, Ahmet Höke, The Journal of Sexual Medicine	2015	21
An optimized dosing regimen of cimaglermin (neuregulin 1β3, glial growth factor 2) enhances molecular markers of neuroplasticity and functional recovery after permanent ischemic stroke in rats Jennifer F. Iaci, Tom J. Parry, Zhihong Huang, Journal of Neuroscience Research Synapse FormationCimaglermin TreatmentSocial SciencesCerebral Vascular RegulationStroke Rehabilitation	2015	18
Transient Changes in Hepatic Physiology That Alter Bilirubin and Bile Acid Transport May Explain Elevations in Liver Chemistries Observed in Clinical Trials of GGF2 (Cimaglermin Alfa) Merrie Mosedale, Donald Button, Jonathan P. Jackson, Toxicological Sciences Cimaglermin AlfaPathologyCholangiopathiesOxidative StressChronic Heart Failure	2017	18
Dalfampridine Improves Sensorimotor Function in Rats With Chronic Deficits After Middle Cerebral Artery Occlusion Jennifer F. Iaci, Tom J. Parry, Zhihong Huang, Stroke	2013	17

Page 1